Q&A: Blocking TGF-beta signals may prevent cancer in liver, GI system

Q&A: Blocking TGF-beta signals may prevent cancer in liver, GI system

Transforming growth factor beta mutation biomarkers may help identify patients at high risk for cancer of the liver, pancreas and gastrointestinal system, according to data published in Gastroenterology.Further studies on targeting and blocking transforming growth factor beta (TGF-beta) may lead to prevention strategies for several cancers and diseases.Healio Gastroenterology spoke with Lopa Mishra, MD, director, Institute of Bioelectronic Medicine at the Feinstein Institutes for Medical Research in Manhasset, New York, about genetic alterations in TGF-beta and the role it may play in theRead More

Share on facebook
Share on twitter
Share on linkedin